Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis

PHASE2CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Hypertension, Portal
Interventions
DRUG

GR-MD-02

GR MD 02 (galactoarabino rhamnogalacturonate), a complex carbohydrate drug that binds to galectin 3

DRUG

Placebo

Placebo for GR-MD-02

Trial Locations (46)

10032

Columbia University Medical Center, New York

11030

North Shore University Hospital, Manhasset

19104

Hospital of The University of Pennsylvania, Philadelphia

19107

Thomas Jefferson University, Philadelphia

21202

Mercy Medical Center, Baltimore

23226

Bon Secours St. Mary's Hospital of Richmond, Richmond

23249

Mcguire Veterans Affairs Medical Center, Richmond

23298

Virginia Commonwealth University, Richmond

23502

Digestive and Liver Disease Specialists, Norfolk

23602

Mary Immaculate Hospital, Newport News

27103

Digestive Health Specialists, Winston-Salem

27710

Duke University Medical Center, Durham

29403

Medical University of South Carolina, Charleston

30309

Piedmont Hospital, Atlanta

32610

University of Florida, Gainesville

33136

University of Miami, Miami

33157

IMIC, Palmetto Bay

33606

Tampa General Medical Group, Tampa

34211

Florida Digestive Health Specialist, Lakewood Rch

44106

University Hospitals Case Medical Center, Cleveland

46202

Indiana University School of Medicine, Indianapolis

48109

University of Michigan, Ann Arbor

48202

Henry Ford Health System, Detroit

55114

Minnesota Gastroenterology PA, Saint Paul

60611

Feinberg School of Medicine, Northwestern University, Chicago

63104

Saint Louis University, St Louis

64128

Kansas City VA Medical Center, Kansas City

70112

Tulane University Health Sciences Center, New Orleans

75246

Texas Digestive Research Center, Dallas

76012

Texas Clinical Research Institute LLC, Arlington

77030

St Luke's Episcopal Hospital, Houston

78215

Texas Liver Institute, San Antonio

78233

Pinnacle Clinical Research, PLLC, Live Oak

78234

San Antonio Military Medical Center, Fort Sam Houston

80045

University of Colorado Denver, Aurora

84107

Intermountain Medical Center, Murray

90048

Cedars Sinai Medical Center, Los Angeles

92103

University of California San Diego Medical Center, San Diego

95817

University of California Davis Medical Center, Sacramento

98104

Swedish Medical Center, Seattle

University of Washington, Seattle

20889-5600

Walter Reed National Military Medical Center, Bethesda

02215

Beth Israel Deaconess Medical Center, Boston

39216-4505

University of Mississippi Medical Center, Jackson

02905

University Gastroenterology, Providence

37212-1610

Vanderbilt University Medical Center, Nashville

Sponsors
All Listed Sponsors
collaborator

Dr. Naga Chalasani, MD, Indiana University

UNKNOWN

collaborator

Dr. Stephen A. Harrison, MD, Brooke Army Medical Center

UNKNOWN

lead

Galectin Therapeutics Inc.

INDUSTRY